Skip to content
APLS Apellis Pharmaceuticals, Inc. Common Stock
$29.50 0.67% +0.20
Notify me if price changes either direction
Interactive Brokers Logotype

Buy APLS stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.7B
Enterprise value 3.8B
Trailing PE -6.7280900076534
Forward PE -35.7381
PEG Ratio -35.7381
Enterprise to EBITDA -16.997
Enterprise to revenue 5.264
Price to book MRQ 15.4503355
Price to sales TTM 5.221189

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 715.2M
EBITDA -221507008
Diluted EPS TTM -2.03
Total Cash (MRQ) 403.7M
Current ratio (MRQ) 4.36
Operating Cash Flow (TTM) -205100992

APLS trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent APLS News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.